USPTO serial 78196878
PLENTI
Reviewed by CopyMark Law Group
Reg. 2963058Status 710
- Filing date
- Status date
- Registration date
- Jun 21, 2005
- Examiner
- BROWN, BRIAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PLENTI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
OXFORD OX4 4GA, GB
OXFORD OX4 4GA, GB
OXFORD OX4 4GA, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ilene B. Tannen
ILENE B TANNEN ESQ JONES DAY222 E 41ST STNEW YORK, NY 10017UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals for use in the manufacture of viruses, vectors, pharmaceuticals and retroviral vector preparations for use in industry, science and medical science; enzymes and chemical products for in vitro use in laboratories and for analysis in and development of gene delivery technology; micro organisms, cell cultures, plasmids and cultures of micro organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid and variations thereof, all for in vivo or ex vivo use in gene delivery technology and cloning technology | SECTION 8 - CANCELLED | — |
| 005 | clinical medical reagents for use in gene therapy, pharmaceutical preparations for use in gene therapy,enzymes and enzyme preparations for medical purpose, for use in gene delivery and cloning technology, retroviral vector and retroviral vector manufacturing preparations for use in gene delivery and cloning technology | SECTION 8 - CANCELLED | — |
| 042 | scientific and medical research and development, and product development; genetic engineering services, biotechnology services, namely research and development of new products for others in the field of gene technology and gene therapy | SECTION 8 - CANCELLED | — |
| 044 | Medical Services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks owned by Oxford BioMedica plc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named PLENTI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 21, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 29, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 9, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 28, 2004 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 22, 2004 | ALIE | ASSIGNED TO LIE | — |
| Sep 13, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 24, 2004 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Aug 24, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 4, 2004 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Jun 4, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 4, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2004 | PAPER RECEIVED | — | |
| Dec 8, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 29, 2003 | PAPER RECEIVED | — | |
| Oct 27, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 13, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2003 | DOCK | ASSIGNED TO EXAMINER | — |